Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank67
3Y CAGR+1.1%
5Y CAGR+20.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+1.1%/yr
Annual compound
5Y CAGR
+20.9%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $44.79M | -17.0% |
| 2024 | $53.97M | +6.4% |
| 2023 | $50.72M | +17.1% |
| 2022 | $43.32M | +51.5% |
| 2021 | $28.60M | +65.2% |
| 2020 | $17.31M | +270.9% |
| 2019 | $4.67M | - |